RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin-RGD interactions.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin-RGD interactions.
- Published In:
- Cancer medicine, 13(2), e6800 (2024)
- Authors:
- Javid, Hossein(4), Oryani, Mahsa Akbari, Rezagholinejad, Nastaran, Esparham, Ali, Tajaldini, Mahboubeh, Karimi-Shahri, Mehdi
- Database ID:
- RPEP-08465
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08465APA
Javid, Hossein; Oryani, Mahsa Akbari; Rezagholinejad, Nastaran; Esparham, Ali; Tajaldini, Mahboubeh; Karimi-Shahri, Mehdi. (2024). RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin-RGD interactions.. Cancer medicine, 13(2), e6800. https://doi.org/10.1002/cam4.6800
MLA
Javid, Hossein, et al. "RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin-RGD interactions.." Cancer medicine, 2024. https://doi.org/10.1002/cam4.6800
RethinkPeptides
RethinkPeptides Research Database. "RGD peptide in cancer targeting: Benefits, challenges, solut..." RPEP-08465. Retrieved from https://rethinkpeptides.com/research/javid-2024-rgd-peptide-in-cancer
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.